Aug 17, 2017

Why venture capitalists are tapping into the cryptocurrency boom

Rebecca Zisser / Axios

Top-tier venture capital firms are quietly taking advantage of the recent explosion in new cryptocurrencies, with many backing so-called "crypto hedge funds" that trade and invest in cryptocurrencies, usually at their earliest stages. Others are experimenting alone.

Why it matters: More than $1.5 billion has been raised through initial coin offerings — or ICOs — so far this year. In many cases they can serve as an alternative funding mechanism to traditional venture capital, so backing crypto hedge funds can help VCs maintain a piece of the action.

In the spring, for example, venture firms including Sequoia Capital, Andreessen Horowitz and Union Square Ventures reportedly invested in a crypto hedge fund called MetaStable. Another crypto hedge fund called Polychain has raised from some of the same shops, while other VC firms like CrunchFund are directly participating in cryptocurrency token sales.

Explainer: ICOs are a form of crowdfunding through which a cryptocurrency project sells part of its pool of tokens (future cryptocurrencies) to early backers.

  • Usually, these tokens are sold for Bitcoin or another digital currency, and the fundraising often happens before the project begins —as a way to fund its development.
  • Similar to company stock, investors hope that the value of these future cryptocurrencies will increase once they start trading publicly.
  • Many ICOs involve a "pre-sale" during which a subset of the tokens are sold to a select group of investors (often professional investors) before the official ICO takes place, usually at a slightly higher price.

The funds: Cryptocurrency hedge funds are cropping up quickly—there are already dozens of them, according to a recent Hedge Fund Alert report. Axios primarily spoke to people involved with three of them: MetaStable, Polychain Capital, and one managed by Pantera Capital. While their investment strategies vary, all focus on purchasing cryptocurrencies and tokens.

Why VCs are interested:

  • Familiarity: It's cliché, but a lot of VC interest in these early-stage tech projects is because it's similar to investing in startups. "They're all about envisioning the future and predicting the future," MetaStable co-founder Josh Seims told Axios of venture capitalists. "And the story of crypto is very synergistic with the future." One VC at a well-known Silicon Valley firm said projects fundraising though token sales are similar to startups because they have small teams, usually with just a white paper detailing the tech they want to build. He also compared backing these hedge funds with putting money into Y Combinator, which gives VCs a bit of exposure to the accelerator's portfolio companies.
  • Vetting: Similarly to startups, there's an emphasis on picking viable projects with qualified teams, though multiple experts emphasized to Axios that technical abilities are much more important than in the case of a startup building a photo-sharing app. Pantera Capital partner Paul Veradittakit added: "If they're raising Series C or Series D level capital, I'm really gonna have to be comfortable with those teams not only to build the tech but also be good stewards with that money." As for selecting hedge funds to back, it comes down to manager expertise and networks in the nascent community, giving them the ability to spot the best projects and teams early.
  • Education: Tokens and cryptocurrencies are a new asset class and many investors want to explore it, especially after "the meteoric rise of Bitcoin and Ethereum," according to Seims. It may also yield better returns than investing venture capital into a company building tools for cryptocurrencies. "Investing in the companies has risks," he says. "Even Coinbase, if you participated in the Series A back then, you would do about as well as well as if you bought Bitcoin back then."

Where the money comes from: It depends. As Seims points out, many VC funds don't have charters that allow them to invest in these new assets. Early on, VCs were investing their personal money into MetaStable, for example. Pantera Capital's ICO-focused fund is separate from its VC fund, though both have similar kinds of limited partners. As for Sequoia Capital, a source says that it doesn't have a separate pool for crypto hedge fund investments.

What's next?

There are still a lot of unanswered questions when it comes to regulations, although the SEC recently warned that some token sales could be subject to securities laws. And of course there's the question of whether ICOs will replace venture capital altogether, though investors' have differing views on that point.

Go deeper

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3 a.m. ET: 665,164 — Total deaths: 30,852 — Total recoveries: 140,225.
  2. U.S.: Leads the world in cases. Total confirmed cases as of 3 a.m. ET: 124,665 — Total deaths: 2,191 — Total recoveries: 1,095.
  3. Federal government latest: President Trump announces new travel advisories for New York, New Jersey and Connecticut, but rules out quarantine enforcement. Per the CDC, residents of those states must now "refrain from non-essential domestic travel for 14 days," with the exception of critical infrastructure industry workers.
  4. State updates: Alaska is latest state to issue a stay-at-home order — New York is trying to nearly triple its hospital capacity in less than a month and has moved its presidential primary to June 23. Some Midwestern swing voters who backed Trump's handling of the virus less than two weeks ago are balking at his call for the U.S. to be "opened up" by Easter.
  5. World updates: In Spain, over 1,400 people were confirmed dead between Thursday to Saturday.
  6. 🚀 Space updates: OneWeb filed for bankruptcy amid the novel coronavirus pandemic.
  7. Hollywood: Tom Hanks and Rita Wilson have returned to U.S. after being treated for coronavirus.
  8. What should I do? Answers about the virus from Axios expertsWhat to know about social distancingQ&A: Minimizing your coronavirus risk
  9. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Coronavirus updates: Global death toll tops 30,000

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens and confirmed plus presumptive cases from the CDC

The novel coronavirus has now killed more than 30,000 people around the world — with Italy reporting over 10,000 deaths, per Johns Hopkins data.

The big picture: The number of deaths from COVID-19 in the U.S. surpassed 2,000 on Saturday. The United States leads the world in confirmed coronavirus infections — more than 124,000 by early Sunday. The number of those recovered from the virus in the U.S. passed the 1,000-mark on Saturday evening.

Go deeperArrowUpdated 4 mins ago - Health

Gilead expands access to experimental coronavirus drug in emergency cases

Photo: Olivier Douliery/AFP via Getty Images

Gilead Sciences CEO Daniel O’Day said in an open letter Saturday the company is expanding access to its experimental anti-coronavirus drug remdesivir to include severely ill COVID-19 patients.

The big pig picture: President Trump has called the antiviral drug "promising," but the results of six clinical trials on this investigational medicine are still being conducted, so its effectiveness in COVID-19 the treatment has yet to be proved. The World Health Organization is involved in the tests.

Go deeperArrow26 mins ago - Health